Oncobiologics (OTLK)
(Delayed Data from NSDQ)
$8.60 USD
+0.10 (1.18%)
Updated May 3, 2024 04:00 PM ET
After-Market: $8.58 -0.02 (-0.23%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.88 | 0.00% |
Earnings Summary
For their last quarter, Oncobiologics (OTLK) reported earnings of -$0.80 per share, beating the Zacks Consensus Estimate of $-1.00 per share. This reflects a positive earnings surprise of 20.00%. Look out for OTLK's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.88 per share, reflecting a year-over-year decrease of 46.67%.
Earnings History
Price & Consensus
Zacks News for OTLK
Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study
OTLK: What are Zacks experts saying now?
Zacks Private Portfolio Services